Treatment for inflammatory acne is expected to account for significant market revenue share gain over the forecast period
The inflammatory acne segment is the largest acne type segment in the global acne treatment market, which is estimated to create a little more than US$ 3,000 Mn, or close to 60% share of the total market in 2017 and more than US$ 4,500 Mn, or a little over 60% by 2025 end, expanding at a CAGR of 5% over the forecast period. The segment is expected to gain 195 BPS in its market share by 2025 over 2017. The inflammatory acne segment is expected to create absolute $ opportunity of US$ 145.7 Mn in 2018 over 2017. By acne type, the inflammatory acne segment dominated the global acne treatment market in terms of revenue in 2017, and the trend is projected to continue throughout the forecast period. The inflammatory acne segment is the most attractive segment, anticipated to record an attractiveness index of 1.3 over the forecast period.
Changing societal habits of people are prompting early onset of acne, thereby fueling the global acne treatment market growth exponentially
The psychological burden associated with acne is high, which leads patients to seek professional help in the form of prescription treatments, be it with antibiotics or combination treatments. Statistics acquired from acnetreatment.org.uk have revealed that 92% patients suffering from acne have felt depression while 14% have felt suicidal tendencies as well. This creates immediate demand for acne treatments, which in turn is expected to fuel revenues in the global acne treatment market.
Request for Sample Report : https://www.persistencemarketresearch.com/samples/5279
Globally, the demand for minimally invasive cosmetic treatment procedures is increasing significantly. Dermatologists prefer to treat skin diseases through the use of topical applications or less invasive procedures rather than surgical methods. More informed decision making, better patient-physician relationships and well documented procedures are leading to increasing demand for treatments pertaining to face and skin related problems. This has been driving adoption of various less painful aesthetic combination therapy procedures. Further, increasing demand for faster treatments and quicker results are factors expected to drive demand for equipment based procedures such as lasers.
Laser treatments usually offer a permanent solution for skin problems and reduce the probability of future problems such as further growth of facial hair and pigmentation issues. Furthermore, laser treatments are also less painful than other treatment types, which increase the chances of easier patient adaptability. To permanently minimize the occurrence of acne, clinicians suggest the use of combination therapy such as a topical antibiotic with a retinoid. Designing effective yet well tolerated medication regimes offering simplified dosages that suit patient lifestyles are more likely to optimize adherence and outcomes. The availability of well-trained dermatologists, who can effectively involve patients in treatment designing are the critical agents expected to fuel the revenue growth of the global acne treatment market.
Request for methodology : https://www.persistencemarketresearch.com/methodology/5279
Inflammatory acne type segment is likely to show good growth across the various regional acne treatment markets
The inflammatory acne segment dominated the Europe acne treatment market in terms of revenue in 2017, and the trend is projected to continue throughout the forecast period. Inflammatory acne segment is the most attractive segment by acne type in the Europe regional market, with a market attractiveness index of 1.0 over the forecast period. In the APAC acne treatment market, the inflammatory acne segment is likely to register a CAGR of 5.4% during the period of forecast. In MEA, the inflammatory acne segment is projected to show substantial growth throughout the forecast period. Inflammatory acne segment is the most attractive segment in the MEA acne treatment market, with a market attractiveness index of 1.3 over the forecast period.